14 studies found for:    "Nevoid basal cell carcinoma syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Nevoid basal cell carcinoma syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome
Conditions: Basal Cell Carcinoma;   Gorlin Syndrome;   Nevoid Basal Cell Carcinoma Syndrome
Interventions: Drug: LDE225;   Drug: Placebo
2 Active, not recruiting The Purpose of This Study is to Determine The Efficacy and Safety of a Systemic Hedgehog Pathway Antagonist (GDC-0449) in Patients With Basal Cell Nevus Syndrome (BCNS)
Conditions: Basal Cell Nevus Syndrome;   Gorlin Syndrome
Intervention: Drug: GDC-0449
3 Terminated Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Conditions: Basal Cell Carcinoma;   Nevoid Basal Cell Carcinoma Syndrome;   Gorlin Syndrome
Intervention: Drug: verteporfin PDT
4 Completed A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients
Condition: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Interventions: Drug: Placebo;   Drug: LDE225;   Drug: LDE225 0.25%;   Drug: LDE225 0.75%
5 Active, not recruiting Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
Condition: Basal Cell Nevus Syndrome
Intervention: Drug: BMS-833923
6 Active, not recruiting Trial Comparing the Effects of Intermittent Vismodegib Versus Photodynamic Therapy in Patients With Multiple Basal Cell Carcinomas
Conditions: Basal Cell Nevus Syndrome;   Gorlin's Syndrome
Interventions: Drug: GDC-0449;   Procedure: Aminolevulinic acid %20 topical solution + blue light
7 Completed Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Conditions: Skin Cancer;   Xeroderma Pigmentosum;   Basal Cell Nevus Syndrome
Intervention:
8 Unknown  Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Conditions: Neoplastic Syndrome;   Non-Melanomatous Skin Cancer
Interventions: Drug: sirolimus;   Genetic: comparative genomic hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Procedure: biopsy
9 Completed Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
Conditions: Neoplastic Syndrome;   Non-melanomatous Skin Cancer
Intervention: Drug: tazarotene
10 Completed Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Conditions: Neoplastic Syndrome;   Non-melanomatous Skin Cancer
Interventions: Drug: tazarotene;   Other: placebo
11 Completed Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Condition: Non-melanomatous Skin Cancer
Intervention: Drug: celecoxib
12 Completed Isotretinoin in Preventing Skin Cancer
Conditions: Melanoma (Skin);   Non-melanomatous Skin Cancer
Intervention: Drug: isotretinoin
13 Completed A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
Condition: Basal Cell Carcinoma
Intervention:
14 Completed Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer
Condition: Basal Cell Carcinomas
Intervention: Device: PulseCure pulse generator and Derm-pulse electrode

Indicates status has not been verified in more than two years